Dr. Rink’s laboratory is focused on neural and cerebrovascular adaptations that protect the brain from stroke injury. These adaptations include the formation and recruitment of collateral blood supply, leveraging endogenous glutamate metabolizing enzymes to mitigate neurotoxicity, and mechanisms of post-stroke neuroplasticity that facilitate recovery from stroke-induced loss of motor function.


  • PhD: The Ohio State University
  • MBA: The Ohio State University

Research Interests

  • Cerebrovascular injury
  • Stroke therapeutics
  • Pre-clinical models of disease and injury
  • Residual limb health and amputee care
  • Non-coding RNA

Current Funding

  • NIH R01 NS085272
  • NIH R01 NS42617
  • NIH R21 NS099869
  • DoD Congressionally Directed Medical Research Program Clinical Trial Award
PubMed articles